The effect of variable dose and release kinetics on neointimal hyperplasia using a novel paclitaxel-eluting stent platform
J. Am. Coll. Cardiol
; J. Am. Coll. Cardiol;46(2): 253-260, 2005. ilus, tab
Article
en En
| SES-SP, SESSP-IDPCPROD, SES-SP
| ID: biblio-1063731
Biblioteca responsable:
BR79.1
Ubicación: BR79.1
ABSTRACT
The aim of this study was to evaluate th effect of variable dose and release kinetics of paclitaxel on neointimal hyperplasia.Conventional paclitaxel-eluting stents use a durable polymer coating as vehicle for drug delivery.The Conor stent (Conor Medsystem, Menlo Park, Califórnia) with intra-strut wells and erodable polymer is specifically designed for drug delivery with programmable pharmakocinetics.Two hundred and forty-four patients with single vessel disease received either a bare metal Conor stent(n=53) or one of six different release formulations that varied in dose (10 or 30yg) and elution release kinetics (first order, zero oder), direction (abluminal, luminal), and duration (5, 10, and 30 days)...
Search on Google
Colección SES:
Producao_cientifica
Banco de datos:
SES-SP
/
SESSP-IDPCPROD
Asunto principal:
Stents
/
Paclitaxel
/
Hiperplasia
Idioma:
En
Año:
2005
Tipo del documento:
Article